<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Chen KC</submitter><funding>Medical Research Council</funding><funding>National Institute for Health Research (NIHR)</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>The hyper-function of the striatal dopamine system has been suggested to underlie key pathophysiological mechanisms in schizophrenia. Moreover, patients have been observed to present a significant elevation of dopamine receptor availability compared to healthy controls. Although it is difficult to measure dopamine levels directly in humans, neurochemical imaging techniques such as single-photon emission computed tomography (SPECT) provide indirect indices of in vivo dopamine synthesis and release, and putative synaptic levels.&lt;h4>Methods&lt;/h4>We focused on the role of dopamine postsynaptic regulation using [123I] iodobenzamide (IBZM) SPECT. We compared D2/3 receptor availability between 53 healthy controls and 21 medication-naive patients with recent-onset schizophrenia.&lt;</pubmed_abstract><journal>Psychological medicine</journal><pagination>1-9</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9693693</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Striatal dopamine D&lt;sub>2/3&lt;/sub> receptors in medication-naive schizophrenia: an [&lt;sup>123&lt;/sup>I] IBZM SPECT study.</pubmed_title><pmcid>PMC9693693</pmcid><funding_grant_id>PDA/02/06/016</funding_grant_id><funding_grant_id>NIHR200756</funding_grant_id><funding_grant_id>G0901310</funding_grant_id><pubmed_authors>Chen KC</pubmed_authors><pubmed_authors>Yeh TL</pubmed_authors><pubmed_authors>Chiu NT</pubmed_authors><pubmed_authors>David AS</pubmed_authors><pubmed_authors>Howes OD</pubmed_authors><pubmed_authors>Lee IH</pubmed_authors><pubmed_authors>Chen PS</pubmed_authors><pubmed_authors>Bramon E</pubmed_authors><pubmed_authors>Yang YK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Striatal dopamine D&lt;sub>2/3&lt;/sub> receptors in medication-naive schizophrenia: an [&lt;sup>123&lt;/sup>I] IBZM SPECT study.</name><description>&lt;h4>Background&lt;/h4>The hyper-function of the striatal dopamine system has been suggested to underlie key pathophysiological mechanisms in schizophrenia. Moreover, patients have been observed to present a significant elevation of dopamine receptor availability compared to healthy controls. Although it is difficult to measure dopamine levels directly in humans, neurochemical imaging techniques such as single-photon emission computed tomography (SPECT) provide indirect indices of in vivo dopamine synthesis and release, and putative synaptic levels.&lt;h4>Methods&lt;/h4>We focused on the role of dopamine postsynaptic regulation using [123I] iodobenzamide (IBZM) SPECT. We compared D2/3 receptor availability between 53 healthy controls and 21 medication-naive patients with recent-onset schizophrenia.&lt;</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Mar</publication><modification>2025-04-19T23:05:20.722Z</modification><creation>2025-04-19T23:05:20.722Z</creation></dates><accession>S-EPMC9693693</accession><cross_references><pubmed>33682657</pubmed><doi>10.1017/S0033291720005413</doi></cross_references></HashMap>